Niagen Bioscience, Inc. Common Stock

NAGENASDAQUSD
3.67 USD
0.03 (0.81%)AT CLOSE (11:59 AM EDT)
3.75
0.08 (2.04%)
POST MARKET (AS OF 07:08 PM EDT)
Post Market
AS OF 07:08 PM EDT
3.75
0.08 (2.04%)
🔴Market: CLOSED
Open?$3.70
High?$3.79
Low?$3.65
Prev. Close?$3.70
Volume?658.7K
Avg. Volume?879.3K
VWAP?$3.71
Rel. Volume?0.75x
Bid / Ask
Bid?$3.18 × 100
Ask?$4.21 × 100
Spread?$1.03
Midpoint?$3.70
Valuation & Ratios
Market Cap?294.7M
Shares Out?79.6M
Float?48.4M
Float %?60.5%
P/E Ratio?15.81
P/B Ratio?3.58
EPS?$0.23
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
Employees
117
Market Cap
290.7M
Industry
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Listed
2008-06-24
Address
10900 WILSHIRE BLVD
LOS ANGELES, CA 90024
Phone: 310-388-6706
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?4.61Strong
Quick Ratio?3.55Strong
Cash Ratio?2.92Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score
78/100
P/E?
15.8CHEAP
P/B?
3.58FAIR
P/S?
2.26CHEAP
P/FCF?
71.8PRICEY
EV/EBITDA?
16.3FAIR
EV/Sales?
1.75CHEAP
Returns & Efficiency
ROE?
22.6%STRONG
ROA?
16.3%STRONG
Cash Flow & Enterprise
FCF?$4.1M
Enterprise Value?$228.1M
Fundamentals ratios updated end of day